* National Health Investors Inc NHI.N NHI is expected
to show
a fall in quarterly revenue when it reports results on November
5 for the period ending September 30 2024
* The Murfreesboro Tennessee-based company is expected to
report
a 1.1% decrease in revenue to $79.206 million from $80.11
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data. (SAL is on Total Revenue basis)
* LSEG's mean analyst estimate for National Health
Investors Inc
is for earnings of 73 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for National
Health
Investors Inc is $87.00, above its last closing price
of $76.45.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 1.10 1.10 1.18 Beat 7.4
Mar. 31 2024 1.05 1.06 1.12 Beat 5.7
Dec. 31 2023 1.07 1.07 1.09 Beat 1.7
Sep. 30 2023 1.08 1.08 1.08 Met 0
Jun. 1.08 1.08 1.06 Missed -2.3
30 2023
Mar. 31 2023 0.99 1.00 1.11 Beat 11.4
Dec. 31 2022 1.09 1.09 0.85 Missed -22.2
Sep. 30 2022 1.06 1.07 1.06 Missed -0.6
This summary was machine generated November 2 at 03:50 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)